UnityPoint Health Ventures

At UnityPoint Health, they’re committed to investing in ideas and partners that provide an easier, more personal experience for their patients and providers. That’s why they founded their Innovation Venture Fund in 2019, which manages financial and strategic investment opportunities.

Austin Duke

Senior Venture Associate

13 past transactions

Pathware

Series A in 2022
Pathware is on a mission to fundamentally improve healthcare by bringing computational microscopy and AI to the Point-of-Care in order to help pathologists and proceduralists accurately diagnose and treat diseases earlier and more precisely, ultimately saving lives globally.

Prolucent Health

Series A in 2021
Prolucent Health provides technology and services that empower modern workforce management.

b.well Connected Health

Series B in 2021
b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for consumer engagement, holistic health management, and cost containment. It specializes in and supports health plans, health systems, employers, and pharmaceutical companies. The platform aims to empower users to manage and optimize their healthcare experience by aggregating information from various sources, such as electronic health records, wearable devices, and other health apps.

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

DocStation

Seed Round in 2021
DocStation is a software platform that connects payers & pharmacists to run value-based programs. Over 500 providers are working with innovative health plans on DocStation. We believe the future of pharmacy is value-based. Equipping pharmacists with the right tools aligns goals for all stakeholders, leading to better outcomes at a lower cost.

SilverCloud Health

Series B in 2020
SilverCloud Health provides immediate access to evidence-based and supported digital therapies. SilverCloud’s engagement has shown a three-fold increase in client/patient engagement and a three-fold decrease in client/patient program dropout when compared with current leading online therapeutic products. It was founded in 2011 and headquartered in Boston, Massachusetts.

Bright.md

Series C in 2020
Bright.md is a developer of an AI-powered virtual-care platform designed to modernize direct-to-patient telehealth for healthcare systems. The company partners with premier healthcare organizations to offer SmartExam to more than 10 million patients who are seeking convenient urgent and primary care online, connecting them to their physicians via a home computer or mobile device reducing visits, enabling patients to receive conveniently, high quality, asynchronous, online care from established and trusted health system providers. The company was founded in 2014 and is based in Portland, Oregon.

VIDA

Series C in 2020
VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.

b.well Connected Health

Series A in 2020
b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for consumer engagement, holistic health management, and cost containment. It specializes in and supports health plans, health systems, employers, and pharmaceutical companies. The platform aims to empower users to manage and optimize their healthcare experience by aggregating information from various sources, such as electronic health records, wearable devices, and other health apps.

CareSignal

Venture Round in 2020
CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.

Kaizen Health

Series B in 2020
Kaizen Health is a healthcare mobility company that is improving access, quality, satisfaction and efficiency in health care by removing transportation as a barrier. Top healthcare delivery systems, payers, senior living, clinical trials and municipalities are utilizing Kaizen Health’s industry-leading technology and transportation network to address social determinants of health within and outside of health care to better promote health equity.

CareSignal

Seed Round in 2019
CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.

VIDA

Corporate Round in 2019
VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.